[HTML][HTML] Reappraisal of idiopathic CD4 lymphocytopenia at 30 years
…, MV Anderson, A Mateja, E Laidlaw… - … England Journal of …, 2023 - Mass Medical Soc
Background Idiopathic CD4 lymphocytopenia (ICL) is a clinical syndrome that is defined by
CD4 lymphopenia of less than 300 cells per cubic millimeter in the absence of any primary or …
CD4 lymphopenia of less than 300 cells per cubic millimeter in the absence of any primary or …
[HTML][HTML] Persistent Oxidative Stress and Inflammasome Activation in CD14highCD16− Monocytes From COVID-19 Patients
SL Lage, EP Amaral, KL Hilligan, E Laidlaw… - Frontiers in …, 2022 - frontiersin.org
The poor outcome of the coronavirus disease-2019 (COVID-19), caused by SARS-CoV-2, is
associated with systemic hyperinflammatory response and immunopathology. Although …
associated with systemic hyperinflammatory response and immunopathology. Although …
Clinical, virologic, and immunologic evaluation of symptomatic coronavirus disease 2019 rebound following nirmatrelvir/ritonavir treatment
…, JM Rocco, KL Boswell, E Laidlaw… - Clinical Infectious …, 2023 - academic.oup.com
Background Nirmatrelvir/ritonavir, the first severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
protease inhibitor, reduces the risk of hospitalization and death by …
protease inhibitor, reduces the risk of hospitalization and death by …
[HTML][HTML] Activation of complement components on circulating blood monocytes from COVID-19 patients
SL Lage, JM Rocco, E Laidlaw, A Rupert… - Frontiers in …, 2022 - frontiersin.org
The coronavirus disease-2019 (COVID-19) caused by the SARS-CoV-2 virus may vary from
asymptomatic to severe infection with multi-organ failure and death. Increased levels of …
asymptomatic to severe infection with multi-organ failure and death. Increased levels of …
Increased Metabolic Activity on 18F-Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography in Human Immunodeficiency Virus–Associated …
…, G Roby, D Metzger, E Laidlaw… - Clinical Infectious …, 2019 - academic.oup.com
Background Immune reconstitution inflammatory syndrome (IRIS) represents an unexpected
inflammatory response shortly after initiation of antiretroviral therapy (ART) in some human …
inflammatory response shortly after initiation of antiretroviral therapy (ART) in some human …
Mycobacterial immune reconstitution inflammatory syndrome in HIV is associated with protein-altering variants in hemophagocytic lymphohistiocytosis-related genes
JM Rocco, E Laidlaw, F Galindo… - The Journal of …, 2023 - academic.oup.com
People with HIV (PWH) and mycobacterial infections can develop immune reconstitution
inflammatory syndrome (IRIS) after starting antiretroviral therapy. The pathophysiology of …
inflammatory syndrome (IRIS) after starting antiretroviral therapy. The pathophysiology of …
Severe mycobacterial immune reconstitution inflammatory syndrome (IRIS) in advanced human immunodeficiency virus (HIV) has features of hemophagocytic …
JM Rocco, E Laidlaw, F Galindo… - Clinical Infectious …, 2023 - academic.oup.com
Background People with HIV and mycobacterial infections can develop immune
reconstitution inflammatory syndrome (IRIS) after starting antiretroviral therapy (ART). Severe …
reconstitution inflammatory syndrome (IRIS) after starting antiretroviral therapy (ART). Severe …
[HTML][HTML] Prevalence and pathogenicity of autoantibodies in patients with idiopathic CD4 lymphopenia
…, JS Bourgeois, A Lisco, E Laidlaw… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Idiopathic CD4 lymphopenia (ICL) is defined by persistently low CD4 + cell
counts (<300 cells/μL) in the absence of a causal infection or immune deficiency and can …
counts (<300 cells/μL) in the absence of a causal infection or immune deficiency and can …
[HTML][HTML] Plasma metabolomics reveals dysregulated metabolic signatures in HIV-associated immune reconstitution inflammatory syndrome
…, EW Dahlstrom, F Galindo, E Laidlaw… - Frontiers in …, 2021 - frontiersin.org
Immune reconstitution inflammatory syndrome (IRIS) is an inflammatory complication
associated with an underlying opportunistic infection that can be observed in HIV-infected …
associated with an underlying opportunistic infection that can be observed in HIV-infected …
[HTML][HTML] COVID-19 redux: clinical, virologic, and immunologic evaluation of clinical rebound after nirmatrelvir/ritonavir
BP Epling, JM Rocco, KL Boswell, E Laidlaw, F Galindo… - medRxiv, 2022 - ncbi.nlm.nih.gov
Clinical rebound of COVID-19 after nirmatrelvir/ritonavir treatment has been reported. We
performed clinical, virologic, and immune measurements in seven patients with symptomatic …
performed clinical, virologic, and immune measurements in seven patients with symptomatic …